Triple negative breast cancer

被引:3
作者
Ressler S. [1 ]
Mlineritsch B. [1 ]
Greil R. [1 ]
机构
[1] Laboratory of Immunological and Molecular Cancer Research (LIMCR), IIIrd Med. Dep. with Hematol., Med. Oncol., Hemostaseology, Rheumatology and Infect. Dis., Private Medical University Hospital Salzburg, 5020 Salzburg
关键词
Basal-like; Breast cancer; Inferior prognosis; Targeted therapies; Triple negative;
D O I
10.1007/s12254-010-0232-5
中图分类号
学科分类号
摘要
Breast cancer is increasingly recognized a disease very heterogenous in its biological and clinical behaviour. Triple negative breast cancer lacks the expression of estrogen-, progesterone receptors and Her2/neu protein and is characterized by its unique clinical and prognostic features. This review describes the biology, pathology, prognosis, current treatment options and future directions. © Springer-Verlag 2010.
引用
收藏
页码:185 / 189
页数:4
相关论文
共 55 条
[1]  
Nielsen T.O., Hsu F.D., Jensen K., Cheang M., Karaca G., Hu Z., Hernandez-Boussard T., Livasy C., Cowan D., Dressler L., Akslen L.A., Ragaz J., Gown A.M., Gilks C.B., Van De Rijn M., Perou C.M., Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma, Clinical Cancer Research, 10, 16, pp. 5367-5374, (2004)
[2]  
Perou C.M., Sorlie T., Eisen M.B., Et al., Molecular portraits of human breast tumours, Nature, 406, pp. 747-752, (2000)
[3]  
Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., Van De Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Lonning P.E., Borresen-Dale A.-L., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences of the United States of America, 98, 19, pp. 10869-10874, (2001)
[4]  
Rakha E.A., Reis-Filho J.S., Ellis I.O., Et al., Basal-like breast cancer: A critical review, J Clin Oncol, 26, pp. 2568-2581, (2008)
[5]  
Sarrio D., Rodriguez-Pinilla S.M., Hardisson D., Cano A., Moreno-Bueno G., Palacios J., Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype, Cancer Research, 68, 4, pp. 989-997, (2008)
[6]  
Mani S.A., Guo W., Liao M.-J., Eaton E.Ng., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A., The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells, Cell, 133, 4, pp. 704-715, (2008)
[7]  
Honeth G., Bendahl P.O., Ringner M., Et al., The CD44+/CD24- phenotype is enriched in basal-like breast tumors, Breast Cancer Res, 10, (2008)
[8]  
Abraham B.K., Fritz P., McClellan M., Hauptvogel P., Athelogou M., Brauch H., Prevalence of CD44<sup>+</sup>/CD24<sup>-/low</sup> cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis, Clinical Cancer Research, 11, 3, pp. 1154-1159, (2005)
[9]  
Shackleton M., Vaillant F., Simpson K.J., Et al., Generation of a functional mammary gland from a single stem cell, Nature, 439, (2006)
[10]  
Ben-Porath I., Thomson M.W., Carey V.J., Et al., An embryonic stem cell like gene expression signature in poorly differentiated aggressive human tumors, Nat Genet, 40, (2008)